MMinoryx Therapeutics — Seed (estimated) · €2.4M
This was the company's second round, led by 'la Caixa' through its Caixa Innvierte Biomed II fund. It was first reported on 23 Jan 2015 as €1.6M with CDTI, ICF and the Fondation Sanfilippo; exactly how CDTI and ICF took part is not clear. HealthEquity joined with €0.75M on 9 Apr 2015, and Minoryx gave the round's total as €2.4M. The funds took the first drug, for adrenoleukodystrophy, towards clinical trials.
LeadCaixa Capital Risc
RoundSeed (estimated)
Announced23 Jan 2015
CityMataró
SectorHealthtech & Bio · Biotech
Source
M
M
